Hints and tips:
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...The European Medicines Agency is unlikely to grant conditional marketing authorisation to Merck’s Covid-19 antiviral pill this month as it grapples with “problematic” data, according to people familiar with...
...If the FDA grants emergency use authorisation for the drug, the US government has a contract to buy 3.1m courses for $2.2bn....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Grant highlighted stock shortages in the important run up to the festive period, adding: “I’ve never seen such conditions in over 40 years of selling toys.”...
...After Moderna, which had taken large US government grants, agreed a much lower price, Pfizer eventually settled on $19.50 a dose in the initial contract with the US, and equivalents in other western countries...
...But countries are allowed to grant temporary approval for medicines not approved by the EMA in emergencies such as a pandemic....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Of those received, 5.7m were the BioNTech/Pfizer jab; 3.6m were AstraZeneca; 4m were Sinovac of China and 900,000 were Russia’s Sputnik V, coronavirus tsar Hugo López-Gatell told the news conference....
...Dr VK Paul, head of India’s vaccine strategy task force, said New Delhi hoped drugmakers such as Pfizer and Moderna would bring their vaccines to India “as soon as possible”....
...to grant it emergency approval....
...Small companies have done a lot of the running, initially sustained by research grants. But they have struggled to make a return....
...The US took a step closer to approving the Pfizer/BioNTech Covid-19 vaccine on Thursday, after a committee of experts recommended that the Food and Drug Administration grant it an emergency authorisation...
...The EMA says the “conditional marketing authorisation” it plans to grant requires more evidence than the emergency use authorisation issued by London....
...The US drugs regulator has decided to grant emergency approval in the coming days to Johnson & Johnson’s coronavirus vaccine, making it the country’s third vaccine and the first to require only a single...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...BioNTech, which is based in Mainz, received a €375m grant from the German government in September....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Stanley Erck, Novavax chief executive, thanked Operation Warp Speed, which gave the company one of its largest grants to vaccine makers....
...Following a marathon five-hour presentation broadcast live on Sunday, the board of watchdog Anvisa (the Agência Nacional de Vigilância Sanitária) voted unanimously to grant emergency use approval to both...
...One recipient of a small grant from CEPI at the start of the pandemic was Moderna, a biotech company that had yet to bring a product to market....
...The UK has become the first western country to grant approval for a Covid-19 vaccine, paving the way for a mass immunisation programme to begin as early as next week....
...There was also, following this, a big letter signed by a lot of Nobel Prize winners (mostly in the sciences and economics) as well as former world leaders, calling on President Joe Biden’s team to grant...
...The department, on a site in a different state, was surviving on grants from the US National Institutes of Health....
International Edition